These data suggested that deregulation of circ‐GRB10/miR‐328‐5p/ERBB2 pathway was involved in IDD development.44 Restoring the expression of circ‐GRB10 or enhancing the ERBB2 signalling might thus serve a new therapeutic approach for the IDD. The gene discussed is ERBB2; the disease is intervertebral disk degenerative disorder.